
Pitango VC is Israel's largest and longest-standing venture capital fund, founded in 1993. It partners with visionary entrepreneurs from stealth mode through growth via three parallel funds: Pitango First (early-stage), Pitango Growth, and Pitango HealthTech.
Deal activity increased 50% year-over-year (3 deals in the last 12 months). Average disclosed round size is $25.7M (across 69 rounds with reported amounts).
Portfolio
49
Fund Size
—
Top Stage
Unknown
Last 12 Mo
3
Team
Nechemia (Chemi) J. Peres
Managing Partner & Co-Founder
Rami Kalish
Managing Partner & Co-Founder
Aaron Mankovski
Managing Partner
Ayal Itzkovitz
Managing Partner | First
Eyal Niv
Managing Partner | First
Hila Karah
Managing Partner | HealthTech
Isaac Hillel
Managing Partner | Growth
Ittai Harel
Managing Partner | HealthTech
Zeev Binman
Managing Partner & Former CFO
Gad Huldai
General Partner | First
Yair Cassuto
General Partner | First
Amir Faintuch
Venture Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| AAltesa Biosciences | Series B | $75M | Feb 2026 |
| AAltesa | Series B | $75M | Feb 2026 |
| Growth | — | Feb 2026 | |
| RRestore Medical | Series B | $23M | Jul 2025 |
| Series A | $47M | May 2025 | |
| Series A | $50M | Sep 2024 | |
| Series A | $40M | Jul 2024 | |
| Series C | $155M | Aug 2023 | |
| Series A | $15M | Aug 2023 | |
| NNevia Bio | Seed | $3.1M | Aug 2023 |
| Series C | $55M | May 2023 | |
| Seed | $12M | Mar 2023 | |
| VVertos Medical | Series C | $26M | Jan 2023 |
| Unknown | $14.5M | Jan 2023 | |
| Unknown | $105M | Jan 2023 | |
| Unknown | $55M | Jan 2023 | |
| Seed | $2.6M | Oct 2022 | |
| Seed | $8M | Jan 2022 | |
| Unknown | $41.5M | Jan 2022 | |
| Series A | $13M | Jul 2021 | |
| Series C | $30M | Feb 2021 | |
| Series C | $26M | Jan 2021 | |
| TTulip Interfaces | Series C | $100M | Jan 2021 |
| Growth | $11M | Jan 2020 | |
| Unknown | $105M | Jul 2019 |
Top Co-Investors
Last updated: 20 October 2026